---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-063277"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2025-07-11T23:59:59+00:00"
generated_at: "2026-05-18T06:58:44.785632+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics sets 2025 annual meeting for Sep 3; proposal deadline Jul 21

## Summary
- Annual meeting set for September 3, 2025; proxy materials expected available July 24, 2025.
- Stockholder proposals under Rule 14a-8 must be received by July 21, 2025.
- Universal proxy rule notice for director nominations also due by July 21, 2025.

## SEC filing metadata
- accession: 0001213900-25-063277
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2025-07-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390025063277/0001213900-25-063277-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390025063277/ea0248679-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-063277
- JSON: https://secwatch.observer/filing/0001213900-25-063277.json
- Plain text: https://secwatch.observer/filing/0001213900-25-063277.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.